Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.

about

Trabectedin for the treatment of soft tissue sarcomas.Efficacy of trabectedin for the treatment of liposarcoma.Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model

P2860

Q38872192-20CA2532-7D40-4742-B5E5-9E342FEE56F5 Q38951318-ED3023E3-CBD3-4064-9226-CD1FD0F4FB28 Q58736789-9A9ABE15-187D-40DE-92A1-8D17DE83124E

P2860

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.

Item

http://www.wikidata.org/entity/Q35898258

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Trabectedin for inoperable or ...... a retrospective cohort study.

@ast

Trabectedin for inoperable or ...... a retrospective cohort study.

@en

type

Item

label

Trabectedin for inoperable or ...... a retrospective cohort study.

@ast

Trabectedin for inoperable or ...... a retrospective cohort study.

@en

prefLabel

Trabectedin for inoperable or ...... a retrospective cohort study.

@ast

Trabectedin for inoperable or ...... a retrospective cohort study.

@en

P1476

Trabectedin for inoperable or ...... a retrospective cohort study.

@en

P2093

Albiruni R Abdul Razak

http://www.w3.org/2001/XMLSchema#string

Amanda J Cannell

http://www.w3.org/2001/XMLSchema#string

Martin E Blackstein

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.

Trabectedin and its potential in the treatment of soft tissue sarcoma.

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.

P2888

s12885-016-2054-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-016-2054-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brendan C Dickson

Fernando A Angarita

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291385267

http://www.w3.org/2001/XMLSchema#string

P6179

1006235208

http://www.w3.org/2001/XMLSchema#string

P698

26786213

http://www.w3.org/2001/XMLSchema#string

P932

4719676

http://www.w3.org/2001/XMLSchema#string

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.

about

P2860

P2860

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932